logo
AAT Bioquest

Dopamine receptor Inhibitors (IC50, Ki)

Structure
Compound Name
Standard Type
Standard Values (in nM)
RacloprideKi5.1 [1], 8.7 [2]
DopamineIC5015.0 [1]
HaloperidolIC505.0 [1]
ApomorphineIC5025.0 [1]
HarmineKi10000.0 [1]
ButaclamolIC5050.0 [1]
5-OH-DpatIC5016.0 [1]
HarmalanKi10000.0 [1]
NaluzotanKi2000.0 [1]
ChloroethylnorapomorphineIC508000.0 [1]
6-MethoxyharmalanKi10000.0 [1]
(S)-1-Propyl-3-(3-propyl-phenyl)-piperidineKi57.0 [1]
FluororacloprideKi159.0 [1]
(S)-3-(3-Ethynyl-phenyl)-1-propyl-piperidineKi334.0 [1]
(S)-3-(3-Methylsulfanyl-phenyl)-1-propyl-piperidineKi49.0 [1]
(S)-3-Phenyl-1-propyl-piperidineKi222.0 [1]
(S)-3-(3-Bromo-phenyl)-1-propyl-piperidineKi106.0 [1]
6-Benzyloxymethyl-5-[4-(4-chloro-benzylamino)-phenyl]-pyrimidine-2,4-diamineIC5033000.0 [1]
Trifluoromethanesulfonic acid 3-[(3S)-1-propyl-3-piperidinyl]phenyl esterKi40.0 [1]
3-((S)-1-Propyl-piperidin-3-yl)-benzaldehydeKi20.0 [1]
Trifluoro-methanesulfonic acid 3-((S)-1-phenethyl-piperidin-3-yl)-phenyl esterKi11.0 [1]
Toluene-4-sulfonic acid 3-((S)-1-propyl-piperidin-3-yl)-phenyl esterKi162.0 [1]
[4-[(3S)-1-Propylpiperidin-3-yl]-2-(trifluoromethylsulfonyloxy)phenyl] trifluoromethanesulfonateKi1100.0 [1]
Trifluoro-methanesulfonic acid 4-((S)-1-propyl-piperidin-3-yl)-phenyl esterKi1736.0 [1]
(S)-1-Propyl-3-m-tolyl-piperidineKi430.0 [1]
[(3As,9bR)-3-prop-2-enyl-1,2,3a,4,5,9b-hexahydrobenzo[e]indol-6-yl] trifluoromethanesulfonateKi1900.0 [1]
Trifluoro-methanesulfonic acid 2-((S)-1-propyl-piperidin-3-yl)-phenyl esterKi315.0 [1]
2-[2-[5-[2-(Benzyloxy)phenyl]-3-thienyl]phenyl]cyclopropane-1-carboxylic acidKi120.0 [1]
5-(4-(2-Quinolylmethoxy)phenyl)-6-(4-fluorophenyl)pyridine-2(1H)-oneIC501200.0 [1]
3,5-Dichloro-N-[[(2S)-1-(4-fluorobutyl)pyrrolidin-2-yl]methyl]-2-hydroxy-6-methoxybenzamideKi88.5 [1]
3,5-Dichloro-2-hydroxy-6-methoxy-N-[[(2S)-1-propylpyrrolidin-2-yl]methyl]benzamideKi17.3 [1]
N-[[(2S)-1-Butylpyrrolidin-2-yl]methyl]-3,5-dichloro-2-hydroxy-6-methoxybenzamideKi41.1 [1]
3,5-Dichloro-N-[[(2S)-1-(3-fluorobutyl)pyrrolidin-2-yl]methyl]-2-hydroxy-6-methoxybenzamideKi2610.0 [1]
3,5-Dichloro-N-[[(2S)-1-(3-fluoropropyl)pyrrolidin-2-yl]methyl]-2-hydroxy-6-methoxybenzamideKi130.0 [1]
(3-Prop-2-enyl-1,2,3a,4,5,9b-hexahydrobenzo[e]indol-6-yl) trifluoromethanesulfonateKi125.0 [1]
(3-Propyl-1,2,3a,4,5,9b-hexahydrobenzo[e]indol-6-yl) trifluoromethanesulfonateKi89.0 [1]
(4-Propyl-2,3,4a,5,6,10b-hexahydro-1H-benzo[f]quinolin-7-yl) trifluoromethanesulfonateKi21.0 [1]
1-[1-[(2-Chlorophenyl)methyl]-2-oxopyridin-3-yl]-3-(3-ethylphenyl)ureaKi10000.0 [1]
N-(4-Aminophenyl)sulfonyl-N'-ethyl-2,3-diazaspiro[4.4]non-3-ene-2-carboximidamideKi1000.0 [1]
3,5-Dichloro-N-[[(2R)-1-(3-fluorobutyl)pyrrolidin-2-yl]methyl]-2-hydroxy-6-methoxybenzamideKi2620.0 [1]



References

This online tool may be cited as follows

MLA

"Quest Database™ Dopamine receptor Inhibitors (IC50, Ki)." AAT Bioquest, Inc.20 Nov2024https://www.aatbio.com/data-sets/dopamine-receptor-inhibitors-ic50-ki.

APA

AAT Bioquest, Inc. (2024November 20). Quest Database™ Dopamine receptor Inhibitors (IC50, Ki). AAT Bioquest. https://www.aatbio.com/data-sets/dopamine-receptor-inhibitors-ic50-ki.
BibTeXEndNoteRefMan